STAT October 18, 2024
Ed Silverman

The 340B Drug Discount Program was intended to serve hospitals and clinics serving lower-income patients

Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $63 billion in 2023, a 23.4% increase from the previous year, according to the Health Resources & Services Administration, which oversees the program.

The data mark a steady rise...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article